AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
+$0.01 today
- Market cap
- $1.01B
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
Volume 1.54M
Average 1.38M
AHCO Net Income
Bottom-line profit, the starting point for calculating cash from operations.
AdaptHealth Corp.NASDAQ: AHCO
Net Income · Q1 FY2026 · quarter ended Apr 2026
Net income growth accelerates
Q1 FY2026 net income of $16.04M (cash outflow) rose 163.9% year over year, ahead of the -184.7% change in trailing-twelve-month net income. Sequentially, it fell 84.2% from the prior quarter.
Context
- Net income amounted to 2.0% of revenue in FY2025, down 0.9 pp from a year earlier.
- Net income increased in 1 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 5 analysts of -$21.76M (-67.0%) for the fiscal year ending Dec 2026, a step up from the -169.7% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- -$16.04M-84.2% QoQ
- Last fiscal yearDec 2025
- -$66.04M-169.7% YoY
- LTMApr 2026
- -$79.3M-184.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +163.9% | +31.3% | -132.6 pp |
| 1 year | -169.7% | -67.0% | +102.6 pp |
| 3-year CAGR | — | -66.9% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (66.04M) USD
- Year-over-year change
- -169.7%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (66.04M) | -169.7% |
| FY2024 | 2024-12-31 | 94.78M | +114.0% |
| FY2023 | 2023-12-31 | (678.9M) | -1028.3% |
| FY2022 | 2022-12-31 | 73.13M | -53.8% |
| FY2021 | 2021-12-31 | 158.15M | — |
Net Income vs competitors
How AHCO compares with its peers on the latest reported figures
- AHCO's LTM Apr 2026 net income of $79.3M is the 4th largest of the 9 companies compared; the peer median is $9.01M.
- Its year-over-year change of -184.7% is the lowest of 9, against a peer median of +31.1%.
- Net income amounts to 2.8% of revenue for AHCO, versus a peer median of 11.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.66B | +90.1% | +19.3% | 47.1% | |
| LTM Jun 2026 | $135.04M | +154.2% | — | 15.0% | |
| LTM Mar 2026 | $94.55M | -48.6% | +29.3% | 9.2% | |
| LTM Apr 2026 | $79.3M | -184.7% | — | 2.8% | |
| LTM Mar 2026 | $66.44M | -6.4% | +4.2% | 60.3% | |
| LTM Mar 2026 | $24.9M | -9.4% | -35.2% | 7.1% | |
| LTM Mar 2026 | $15.16M | +21.1% | +33.9% | 5.3% | |
| LTM Mar 2026 | $10.1M | +41.1% | +48.4% | 14.1% | |
| LTM Mar 2026 | $7.91M | +148.0% | +616.7% | 5.6% | |
| Peer median (excluding AHCO) | $9.01M | +31.1% | +29.3% | 11.6% | |
Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 158.15M | 73.13M | (678.9M) | 94.78M | (66.04M) |
| Depreciation & Amortization | 258.05M | 351.18M | 420.59M | 365.33M | 381.93M |
| Deferred Income Tax | 22.38M | 18.04M | (62.6M) | 32.05M | 47.16M |
| Stock-Based Compensation | 25.32M | 22.4M | 22.47M | 14.88M | 21.88M |
| Change in Working Capital | (153.31M) | (108M) | (25.11M) | (26.06M) | 66.58M |
| Accounts Receivables | (29.69M) | (209K) | (28.86M) | (26.22M) | 30.99M |
| Inventory | (14.92M) | (6.3M) | 15.53M | (28.07M) | (11.49M) |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (108.7M) | (101.49M) | (11.78M) | 28.22M | 47.08M |
| Other Non-Cash Items | (34.92M) | 17.12M | 804.2M | 60.86M | 150.26M |
| Operating Cash Flow | 275.68M | 373.87M | 480.67M | 541.84M | 601.77M |
| Capital Expenditures | (203.31M) | (391.42M) | (337.46M) | (306.06M) | (382.39M) |
| Acquisitions (Net) | (1.62B) | (19.02M) | (19.69M) | (9.54M) | (42.38M) |
| Purchases of Investments | (1.13M) | (731K) | (128K) | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 5.32M | 121.58M |
| Investing Cash Flow | (1.82B) | (411.17M) | (357.28M) | (310.28M) | (303.19M) |
| Debt Repayment | 1.4B | (36.18M) | (51.77M) | (179.87M) | (268.48M) |
| Common Stock Issued | 278.85M | 0 | 0 | 0 | 1.21M |
| Common Stock Repurchased | 0 | (13.99M) | (29.28M) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (75.68M) | (15.88M) | (11.48M) | (19.08M) | (34.93M) |
| Financing Cash Flow | 1.6B | (66.05M) | (92.53M) | (198.95M) | (302.19M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 49.67M | (103.36M) | 30.86M | 32.62M | (3.61M) |
| Free Cash Flow | 72.37M | (17.56M) | 143.2M | 235.78M | 219.38M |
AdaptHealth Corp.
NASDAQ:AHCO
Intrinsic Alpha fair value
Locked
Current Price
$7.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.